EVENTS:   The Roaring 2020s or a Rerun of the 1970s? - Edward Yardeni/Yardeni Research - 24 Mar 26   Best Equity Short Ideas Conference Call 13 - Thomas Chanos/Badger Consultants & Dr. Aaron Fletcher/Bios Research & Jonathan Telgener/Channel Dynamics & Ed Steele/Iron Blue Financials & John Zolidis/Quo Vadis Capital & Mark Hiley/The Analyst - 26 Mar 26     ROADSHOWS: Chinese Equity Ideas & Channel Checks Across 50 sub-sectors - Don Ma /Horizon Insights   •   London   23 - 27 Mar 26       Long Short European Equity Research - Harry Grist /The Analyst   •   New York   26 Mar 26       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   27 - 27 Mar 26      
Filters

Fortnightly Publication Highlighting Latest Insights From IRF Providers

Company Research

Cellnex (CLNX SM) Spain

Industrials

Insight Investment Research

Robert Crimes views CLNX’s sharp de-rating since 2022 as highly unjustified. Prop. EBITDaL has grown 36%, from €1.8bn in 2022 to €2.4bn in 2025E, yet the share price has declined 26%, massively underperforming the Eurofirst 300. The stock trades on 2025E EV/EBITDaL of 16.7x, a 29% discount to the 22.9x average of its recent disposals. Robert believes CLNX could attract a buyout from a large consortium, such as American Tower, as it offers a non-replicable pan-European network, ranking first or second in eight of the ten countries it operates in. His TP of €69, implies ~135% upside, with CLNX ranking 3rd of 23 on Insight’s Stock Ranking System.

Edition: 221

- 03 October, 2025


Entering the end game of 3 independent TowerCos in Europe

Industrials

Insight Investment Research

Robert Crimes’ 16-page report details how the European Towers market is to undergo a final phase of consolidation with several large transactions resulting in 3 dominant TowerCos - Cellnex, Vantage Towers and American Tower Europe. He notes that it is significantly more efficient for MNOs to share passive infrastructure while Tower transaction valuations have recently risen allowing MNOs to generate large capital releases to fund investment in 5G and de-lever balance sheets (potential to monetise a further €85bn of Tower assets in Europe). Robert’s preferred stock is Cellnex (well placed to continue to grow acquisitively, raise tenancy and returns); TP €106 (+145%).

Edition: 127

- 21 January, 2022